Answers are grounded in this paper and cite their sources.
. The behavior of nanodiamond carriers depends heavily on their surface coatings, so each therapeutic complex must be evaluated separately. Generally, it seems that site-specific application of nanodiamond carriers is a rather safe therapeutic approach, but intravenous application needs further study. The benefits of nanodiamond carriers are remarkable and represent a potent approach to overcome the drug resistance of many cancers.
No takes yet. Share an insight, caveat, or question.
Benson et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: